ArticleHaematologica2018

Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.

Esteban Enrique Elías et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.